TipRanks
Karyopharm Therapeutics (DE:25K0)
FRANKFURT:25K0
Germany Market
25K0
Karyopharm Therapeutics
RESEARCH TOOLSreports

Karyopharm Therapeutics (25K0) Balance Sheet

1 Followers

Karyopharm Therapeutics Balance Sheet

Karyopharm Therapeutics's total assets for Q2 2026 were $111.32M, a decrease of -15.29% from the previous quarter. DE:25K0 total liabilities were $441.49M for the fiscal quarter, a 11.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 108.42M$ 164.42M$ 240.44M$ 358.17M$ 305.31M
Total Liabilities
$ 401.34M$ 350.44M$ 376.64M$ 374.83M$ 384.98M
Total Equity Gross Minority
$ -292.93M$ -186.02M$ -136.21M$ -16.66M$ -79.67M
Other Metrics
Currency in USD

Karyopharm Therapeutics Debt to Assets